Dabur Buys Minority Stake in RAS Beauty, Plans ₹60 Crore Investment
Dabur India has acquired a minority stake in luxury D2C skincare brand RAS Beauty through Dabur Ventures, with plans to invest around ₹60 crore.
Dabur India Limited has signed a definitive agreement to acquire a minority stake in luxury skincare brand RAS Beauty Private Limited, marking the first investment under its recently launched Dabur Ventures initiative.
Founded by Shubhika Jain along with her sister Suramya Jain and mother Sangeeta Jain, RAS Beauty is a Raipur-based, digital-first “Farm-to-Face” skincare brand positioned in the premium natural beauty segment. The company’s portfolio includes face elixirs, serums and moisturisers infused with essential oils and nature-derived actives. It operates with in-house R&D and manufacturing capabilities, which it says supports clean sourcing and quality control.
According to the company, RAS Beauty has recorded a three-year compound annual growth rate (CAGR) of around 75% and has reached an annual recurring revenue (ARR) of approximately ₹100 crore, alongside strong gross margins. Dabur plans to invest around ₹60 crore in the brand as part of the transaction.
The investment signals Dabur’s strategic intent to tap into India’s fast-growing premium beauty and direct-to-consumer (D2C) segment. Launched in October 2025, Dabur Ventures was set up to acquire stakes in high-potential new-age consumer businesses aligned with the company’s long-term growth roadmap.
Abhinav Dhall, Executive Director – Group Head Corporate Strategy at Dabur India Ltd, said the company sees long-term opportunity in the premium beauty category. “RAS offers a distinct skincare value proposition at the confluence of nature, science and luxury. We believe that the premium beauty segment will witness strong growth in the coming decade and RAS Beauty is well positioned to capture the emerging opportunity,” he said.
India’s beauty and personal care market has seen accelerated growth in the D2C space, particularly in clean beauty, premium skincare and ingredient-led positioning. Consumers are increasingly drawn to brands that combine natural sourcing with scientific claims, while also offering digital accessibility and storytelling-led marketing.
For Dabur, which has traditionally operated across mass and Ayurvedic categories, the minority investment allows it to participate in the premium end of the market without full acquisition risk. Strategic investments in D2C brands offer legacy FMCG companies exposure to agile business models, data-driven consumer insights and faster innovation cycles.
Shubhika Jain, co-founder and CEO of RAS Beauty, said the partnership aligns with the brand’s long-term vision. “Dabur has proved that nature, science, and consumer trust can coexist at scale, and that is exactly what we are building at RAS. This investment will enable us to accelerate our omnichannel presence, deepen our R&D capabilities, and invest in brand and team building,” she said.
The deal also highlights a broader industry pattern: established FMCG players are increasingly investing in emerging D2C brands rather than building premium verticals from scratch. As consumer preferences evolve toward ingredient transparency and luxury positioning, such collaborations provide scale, capital and distribution leverage.
With RAS Beauty as its first portfolio company, Dabur Ventures has signalled its focus on digitally native brands with strong growth trajectories. The coming years will likely see similar strategic bets as traditional players seek relevance in India’s expanding premium beauty landscape.